SlideShare une entreprise Scribd logo
1  sur  23
A Coding-Independent Function of
Gene and Pseudogene mRNAs
Regulates Tumour Biology
by Poliseno, Salmena, and Pandolfi



            Krishna Doppalapudi, Lucas Man,
             Samantha Margulies, Patty Yau
Intro     Main Pts      Results:    Fig. 1       Fig. 2   Fig. 3   Fig. 4   Conclusion




   Introduction
• PTEN is a tumor suppressor gene
    ▫ Its protein product is a phosphatase
      which regulates the cell cycle by
      preventing cells from dividing too rapidly
    ▫ Mutations in this gene are found in many
      cancers
• PTENP1 is the pseudogene of PTEN
    ▫ Pseudogenes are relatives of known                   PTEN
      genes that have lost their ability to be
      translated into protein
    ▫ Once considered nonfunctional                       PTENP1
• PTEN and PTENP1 mRNA transcripts
  show homology
  ▫ Dark grey area is the highly conserved
      region
    ▫ Colored lines show similar miRNA
      binding sites
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion




   Introduction
    • microRNAs: class of small non-coding RNAs
    • miRNAs bind to sequences in the 3’ UTR of
      target mRNAs, resulting in gene silencing
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3    Fig. 4   Conclusion




   Competition for miRNA binding
    • miRNAs can bind to either PTEN or PTENP1
      pseudogene

              miRNAs

                                                 PTEN




                                                 PTENP1
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion




   Main Points of the Paper
   1. PTENP1 is also targeted by PTEN-targeting
      miRNAs
   2. The 3’ UTR of PTENP1 has tumor suppressive
      activity
   3. PTENP1 levels influence downregulation of
      PTEN in cancer cells
   4. PTEN/PTENP1 model should work for other
      genes
Intro        Main Pts    Results:     Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



     1. PTENP1 is targeted by PTEN-
     targeting miRNAs
A.       PTEN is protected from
         miRNA binding by
         PTENP1
B.       Homology
     ▫     PTENP1 is one kb
           shorter
     ▫     Only 18 mismatches
           throughout the entire
           coding sequence
C.       Similar miRNA binding
         sites
     ▫     Perfectly conserved seed
           matches for miRNA 20,
           21, 214, 19, 26
Intro             Main Pts     Results:     Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   1. PTENP1 is targeted by PTEN-
   targeting miRNAs
D. In prostate cancer cells, miRNAs
   19b and 20a suppressed PTEN
   and PTENP1 transcript
   abundance
        ▫         siLuc is used as a control
        ▫         Blue and red bars show a
                  decrease in mRNA
E.          miRNA inhibitors (Imix)
            increased PTENP1 and PTEN
            transcript abundance
        ▫         IC used as a control
                      Without inhibitors
        ▫         Inhibitors cause derepression-
                  miRNAs will not be able to
                  silence the mRNA transcripts
Intro       Main Pts    Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    A. PTENP1 3’ UTR expression
       derepressed PTEN
       transcription and translation
        ▫    Method: PTENP1 3’ UTR
             inserted into DU145 cells
             using retroviral vectors
Intro    Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    B. Elevated PTEN expression is
       related to reduced phospho-
       AKT activity
Intro    Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    B. Elevated PTEN expression is
       related to reduced phospho-
       AKT activity
    C. Effect of derepressed PTEN
       is growth inhibition
Intro       Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    B. Elevated PTEN expression is
       related to reduced phospho-
       AKT activity
    C. Effect of derepressed PTEN
       is growth inhibition
    D. PTENP1 3’ UTR is a more
       potent growth suppressor
       than PTEN
        ▫    Could function as a decoy
             for miRNAs that bind to
             other targets with tumour
             suppressive activities
Intro       Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    E. Disruption of DICER blunts
       derepression of PTEN by
       PTENP1 3’ UTR
        ▫    Suggests PTENP1 3’ UTR
             requires mature miRNA for
             function
Intro         Main Pts     Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    E. Disruption of DICER blunts
       derepression of PTEN by
       PTENP1 3’ UTR
         ▫     Suggests PTENP1 3’ UTR
             siRNA function in RNA
             interferencemature miRNA for
                requires to degrade mRNA,
                function
             introducing siRNA can have the
    F.       Silencing both PTEN and
             effect of “knocking-down” or
             PTENP1 showed strongest
             “silencing” genes
             increase in cell proliferation
         ▫     Suggests additive roles for
               PTEN and PTENP1 in
               growth suppression
Intro       Main Pts    Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    E. Disruption of DICER blunts
       derepression of PTEN by
       PTENP1 3’ UTR
        ▫    Suggests PTENP1 3’ UTR
             requires mature miRNA for
             function
    F. Silencing both PTEN and
       PTENP1 showed strongest
       increase in cell proliferation
        ▫    Suggests additive roles for
             PTEN and PTENP1 in
             growth suppression
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    G. siRNA knockdown decreased
       PTEN and PTENP1 mRNA
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion



   2. The 3’ UTR of PTENP1 has tumor
   suppressive activity
    G. siRNA knockdown decreased
       PTEN and PTENP1 mRNA
    H. siRNA knockdown also
       decreased PTEN protein
       abundance
Intro       Main Pts         Results:        Fig. 1   Fig. 2   Fig. 3
                                                               Fig. 3   Fig. 4   Conclusion



   3. PTENP1 levels influence
   downregulation of PTEN in cancer cells
    A., B. PTEN and PTENP1
         expression are co-regulated
            Method: Quantitative RT
             PCR, measured by green
             fluorescence (Taqman)
            Direct correlation between
             PTEN and PTENP1
             expression in both normal
             tissue and tumour samples
             (r = 0.8087 and 0.7538; P<0.0001)
    C. In colon cancer samples,
       independent copy number
       losses occur specifically in
       PTENP1 gene
            Copy number losses in
             PTENP1 occur due to
             selective pressure in cancer
Intro       Main Pts     Results:    Fig. 1   Fig. 2   Fig. 3
                                                       Fig. 3   Fig. 4   Conclusion



   3. PTENP1 levels influence
   downregulation of PTEN in cancer cells
    D. PTEN expression is
       downregulated in cancer
       cells
    E. PTENP1 transcript levels
       regulate PTEN expression
        ▫   Direct correlation between
            log ratio of PTENP1 copy
            number vs. log10 PTEN
            expression intensity
            1.   r = 0.6105, P = 0.0092
            2.   r = 0.6056, P = 0.0129
Intro      Main Pts      Results:    Fig. 1   Fig. 2   Fig. 3   Fig. 4
                                                                Fig. 4   Conclusion



   4. Model should work for other genes
    A. PTEN 3’ UTR derepresses
       PTENP1 mRNA and shows
       growth suppression
    B. KRAS and its pseudogene
       show similar regulatory
       mechanisms.
        ▫ It is known that K1P 3’ UTR
          overexpression leads to
          increased levels of KRAS, and
          consequently cell proliferation
          and accelerated cell growth
Intro     Main Pts     Results:    Fig. 1   Fig. 2   Fig. 3   Fig. 4
                                                              Fig. 4   Conclusion



   4. Model should work for other genes
    C. RNAs X and Y in this figure
       can be thought of as a
       pseudogene and its cognate
       protein coding gene.
        ▫ In Case 1, the downregulation
          of RNA X leads to increased
          binding sites for the miRNA on
          RNA Y, causing RNA Y to be
          repressed.
        ▫ In Case 2, both RNA X and
          RNA Y are in equilibrium
        ▫ In Case 3, RNA X is
          overexpressed and act as an
          miRNA sponge, this derepresses
          RNA Y
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion




   Conclusion
    • Scientists have discovered a new dimension by
      which cellular and tumor biology can be
      regulated
    • Pseudogenes were once considered non-
      functional, but are now known to affect mRNA
      transcript abundance through a miRNA binding
      mechanism
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion




   References
    • http://www.jyi.org/features/ft.php?id=392
    • http://www.answersingenesis.org/tj/v17/i2/pse
      udogene.asp
    • Nature, Vol 465, 24 June 2010, A coding-
      independent function of gene and pseudogene
      mRNAs regulates tumour biology
Intro   Main Pts   Results:   Fig. 1   Fig. 2   Fig. 3   Fig. 4   Conclusion

Contenu connexe

Tendances

Neuropathic agents
Neuropathic agentsNeuropathic agents
Neuropathic agents
yury
 
AFM-Mohannad-and-Khader-San-Diego-Confrence
AFM-Mohannad-and-Khader-San-Diego-ConfrenceAFM-Mohannad-and-Khader-San-Diego-Confrence
AFM-Mohannad-and-Khader-San-Diego-Confrence
Mohanad Ahmad
 
Regulation of gene expression in prokaryotes
Regulation of gene expression in prokaryotesRegulation of gene expression in prokaryotes
Regulation of gene expression in prokaryotes
sherafatian
 

Tendances (9)

Pten and eph b4 regulate the establishment of perisomatic inhibition in mouse...
Pten and eph b4 regulate the establishment of perisomatic inhibition in mouse...Pten and eph b4 regulate the establishment of perisomatic inhibition in mouse...
Pten and eph b4 regulate the establishment of perisomatic inhibition in mouse...
 
Neuropathic paintx
Neuropathic paintxNeuropathic paintx
Neuropathic paintx
 
Neuropathic agents
Neuropathic agentsNeuropathic agents
Neuropathic agents
 
PurdyPoster2014.1
PurdyPoster2014.1PurdyPoster2014.1
PurdyPoster2014.1
 
AFM-Mohannad-and-Khader-San-Diego-Confrence
AFM-Mohannad-and-Khader-San-Diego-ConfrenceAFM-Mohannad-and-Khader-San-Diego-Confrence
AFM-Mohannad-and-Khader-San-Diego-Confrence
 
ShRNA-specific regulation of FMNL2 expression in P19 cells
ShRNA-specific regulation of FMNL2 expression in P19 cellsShRNA-specific regulation of FMNL2 expression in P19 cells
ShRNA-specific regulation of FMNL2 expression in P19 cells
 
Regulation of gene expression in prokaryotes
Regulation of gene expression in prokaryotesRegulation of gene expression in prokaryotes
Regulation of gene expression in prokaryotes
 
Topoisomerase inhibitor
Topoisomerase inhibitor Topoisomerase inhibitor
Topoisomerase inhibitor
 
Molecular Correlates Of Drug Abuse Comorbidity
Molecular Correlates Of Drug Abuse ComorbidityMolecular Correlates Of Drug Abuse Comorbidity
Molecular Correlates Of Drug Abuse Comorbidity
 

En vedette

Regulation of pten activity by its carboxyl terminal autoinhibitory
Regulation of pten activity by its carboxyl terminal autoinhibitoryRegulation of pten activity by its carboxyl terminal autoinhibitory
Regulation of pten activity by its carboxyl terminal autoinhibitory
Chau Chan Lao
 
Folding by natalia zuleta rendón
Folding by natalia zuleta rendónFolding by natalia zuleta rendón
Folding by natalia zuleta rendón
Natalia Rendón
 
Presentation 2009 Journal Club Azhar Ali Shah
Presentation 2009 Journal Club Azhar Ali ShahPresentation 2009 Journal Club Azhar Ali Shah
Presentation 2009 Journal Club Azhar Ali Shah
guest5de83e
 
Final Journal Club Presentation
Final Journal Club PresentationFinal Journal Club Presentation
Final Journal Club Presentation
Anna Schemel
 
Class immunosuppressants 2
Class immunosuppressants 2Class immunosuppressants 2
Class immunosuppressants 2
Raghu Prasada
 
Schaefer, Joseph, R. Fidaxomicin Presentation
Schaefer, Joseph, R. Fidaxomicin PresentationSchaefer, Joseph, R. Fidaxomicin Presentation
Schaefer, Joseph, R. Fidaxomicin Presentation
Joseph Schaefer
 

En vedette (20)

099 alzalzalah iphone
099 alzalzalah iphone099 alzalzalah iphone
099 alzalzalah iphone
 
Regulation of pten activity by its carboxyl terminal autoinhibitory
Regulation of pten activity by its carboxyl terminal autoinhibitoryRegulation of pten activity by its carboxyl terminal autoinhibitory
Regulation of pten activity by its carboxyl terminal autoinhibitory
 
Folding by natalia zuleta rendón
Folding by natalia zuleta rendónFolding by natalia zuleta rendón
Folding by natalia zuleta rendón
 
Presentation 2009 Journal Club Azhar Ali Shah
Presentation 2009 Journal Club Azhar Ali ShahPresentation 2009 Journal Club Azhar Ali Shah
Presentation 2009 Journal Club Azhar Ali Shah
 
Journal Club @ UVigo 2011.07.22
Journal Club @ UVigo 2011.07.22Journal Club @ UVigo 2011.07.22
Journal Club @ UVigo 2011.07.22
 
Final Journal Club Presentation
Final Journal Club PresentationFinal Journal Club Presentation
Final Journal Club Presentation
 
The Structural Basis for Agonist and Partial Agonist
The Structural Basis for Agonist and Partial AgonistThe Structural Basis for Agonist and Partial Agonist
The Structural Basis for Agonist and Partial Agonist
 
20140328 TNTL journal club axion electrodynamics, TI-FI interface (nomura, ...
20140328 TNTL journal club   axion electrodynamics, TI-FI interface (nomura, ...20140328 TNTL journal club   axion electrodynamics, TI-FI interface (nomura, ...
20140328 TNTL journal club axion electrodynamics, TI-FI interface (nomura, ...
 
Fractura Epicondilo Medial en Niños
Fractura Epicondilo Medial en NiñosFractura Epicondilo Medial en Niños
Fractura Epicondilo Medial en Niños
 
Introduction immunosuppression akl_isneap2017
Introduction immunosuppression akl_isneap2017Introduction immunosuppression akl_isneap2017
Introduction immunosuppression akl_isneap2017
 
Class immunosuppressants 2
Class immunosuppressants 2Class immunosuppressants 2
Class immunosuppressants 2
 
Methods of immunosuppression
Methods of immunosuppressionMethods of immunosuppression
Methods of immunosuppression
 
The PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer pptThe PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer ppt
 
Journal Club - Early versus Late Parenteral Nutrition in Critically Ill Adults
Journal Club - Early versus Late Parenteral Nutrition in Critically Ill AdultsJournal Club - Early versus Late Parenteral Nutrition in Critically Ill Adults
Journal Club - Early versus Late Parenteral Nutrition in Critically Ill Adults
 
Schaefer, Joseph, R. Fidaxomicin Presentation
Schaefer, Joseph, R. Fidaxomicin PresentationSchaefer, Joseph, R. Fidaxomicin Presentation
Schaefer, Joseph, R. Fidaxomicin Presentation
 
Rosenberg on Immunosuppression
Rosenberg on ImmunosuppressionRosenberg on Immunosuppression
Rosenberg on Immunosuppression
 
Rituximab CJASN Journal Club
Rituximab CJASN Journal ClubRituximab CJASN Journal Club
Rituximab CJASN Journal Club
 
Chromosome walking
Chromosome walking Chromosome walking
Chromosome walking
 
Parkinson's Disease Presentation
Parkinson's Disease PresentationParkinson's Disease Presentation
Parkinson's Disease Presentation
 
Tumour supressor gene
Tumour supressor geneTumour supressor gene
Tumour supressor gene
 

Similaire à Pseudogene Journal Club Presentation

Schell Prl2a1 Poster Final
Schell Prl2a1 Poster FinalSchell Prl2a1 Poster Final
Schell Prl2a1 Poster Final
Lance Schell
 
Poster Monterey 2005
Poster Monterey 2005Poster Monterey 2005
Poster Monterey 2005
Anna Öberg
 
Undergraduate Research Symposium Poster
Undergraduate Research Symposium PosterUndergraduate Research Symposium Poster
Undergraduate Research Symposium Poster
Tim Krueger
 

Similaire à Pseudogene Journal Club Presentation (20)

EASD 2009
EASD 2009EASD 2009
EASD 2009
 
Schell Prl2a1 Poster Final
Schell Prl2a1 Poster FinalSchell Prl2a1 Poster Final
Schell Prl2a1 Poster Final
 
Research Proposal
Research ProposalResearch Proposal
Research Proposal
 
poster america
poster americaposter america
poster america
 
Pten jurado
Pten juradoPten jurado
Pten jurado
 
TRISTETRAPROLIN - its role in inflammation and cancer
TRISTETRAPROLIN - its role in inflammation and cancerTRISTETRAPROLIN - its role in inflammation and cancer
TRISTETRAPROLIN - its role in inflammation and cancer
 
Essence of PTEN: a Broad-Spectrum Therapeutic Target in Cancer
Essence of PTEN: a Broad-Spectrum Therapeutic Target in Cancer Essence of PTEN: a Broad-Spectrum Therapeutic Target in Cancer
Essence of PTEN: a Broad-Spectrum Therapeutic Target in Cancer
 
Poster Monterey 2005
Poster Monterey 2005Poster Monterey 2005
Poster Monterey 2005
 
poster2
poster2poster2
poster2
 
Fehrman Nat Gen 2014 - Journal Club
Fehrman Nat Gen 2014 - Journal ClubFehrman Nat Gen 2014 - Journal Club
Fehrman Nat Gen 2014 - Journal Club
 
Targetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion diseaseTargetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion disease
 
Tobacco ring e3 ligase nt rfp1 mediates romance
Tobacco ring e3 ligase nt rfp1 mediates romanceTobacco ring e3 ligase nt rfp1 mediates romance
Tobacco ring e3 ligase nt rfp1 mediates romance
 
CMB 426 Final Report
CMB 426 Final ReportCMB 426 Final Report
CMB 426 Final Report
 
Seminario Biologia molecular Gelena Marsiglia
Seminario Biologia molecular Gelena Marsiglia Seminario Biologia molecular Gelena Marsiglia
Seminario Biologia molecular Gelena Marsiglia
 
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
 
Plegable
PlegablePlegable
Plegable
 
Parkin as a Potential Neuroprotective Agent in a Mouse Model of Parkinson's D...
Parkin as a Potential Neuroprotective Agent in a Mouse Model of Parkinson's D...Parkin as a Potential Neuroprotective Agent in a Mouse Model of Parkinson's D...
Parkin as a Potential Neuroprotective Agent in a Mouse Model of Parkinson's D...
 
Undergraduate Research Symposium Poster
Undergraduate Research Symposium PosterUndergraduate Research Symposium Poster
Undergraduate Research Symposium Poster
 
Seminario biologia molecular final
Seminario  biologia molecular final Seminario  biologia molecular final
Seminario biologia molecular final
 
In press
In pressIn press
In press
 

Dernier

Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 

Dernier (20)

ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu SubbuApidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelNavi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 

Pseudogene Journal Club Presentation

  • 1. A Coding-Independent Function of Gene and Pseudogene mRNAs Regulates Tumour Biology by Poliseno, Salmena, and Pandolfi Krishna Doppalapudi, Lucas Man, Samantha Margulies, Patty Yau
  • 2. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion Introduction • PTEN is a tumor suppressor gene ▫ Its protein product is a phosphatase which regulates the cell cycle by preventing cells from dividing too rapidly ▫ Mutations in this gene are found in many cancers • PTENP1 is the pseudogene of PTEN ▫ Pseudogenes are relatives of known PTEN genes that have lost their ability to be translated into protein ▫ Once considered nonfunctional PTENP1 • PTEN and PTENP1 mRNA transcripts show homology ▫ Dark grey area is the highly conserved region ▫ Colored lines show similar miRNA binding sites
  • 3. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion Introduction • microRNAs: class of small non-coding RNAs • miRNAs bind to sequences in the 3’ UTR of target mRNAs, resulting in gene silencing
  • 4. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion Competition for miRNA binding • miRNAs can bind to either PTEN or PTENP1 pseudogene miRNAs PTEN PTENP1
  • 5. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion Main Points of the Paper 1. PTENP1 is also targeted by PTEN-targeting miRNAs 2. The 3’ UTR of PTENP1 has tumor suppressive activity 3. PTENP1 levels influence downregulation of PTEN in cancer cells 4. PTEN/PTENP1 model should work for other genes
  • 6. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 1. PTENP1 is targeted by PTEN- targeting miRNAs A. PTEN is protected from miRNA binding by PTENP1 B. Homology ▫ PTENP1 is one kb shorter ▫ Only 18 mismatches throughout the entire coding sequence C. Similar miRNA binding sites ▫ Perfectly conserved seed matches for miRNA 20, 21, 214, 19, 26
  • 7. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 1. PTENP1 is targeted by PTEN- targeting miRNAs D. In prostate cancer cells, miRNAs 19b and 20a suppressed PTEN and PTENP1 transcript abundance ▫ siLuc is used as a control ▫ Blue and red bars show a decrease in mRNA E. miRNA inhibitors (Imix) increased PTENP1 and PTEN transcript abundance ▫ IC used as a control  Without inhibitors ▫ Inhibitors cause derepression- miRNAs will not be able to silence the mRNA transcripts
  • 8. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity A. PTENP1 3’ UTR expression derepressed PTEN transcription and translation ▫ Method: PTENP1 3’ UTR inserted into DU145 cells using retroviral vectors
  • 9. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity B. Elevated PTEN expression is related to reduced phospho- AKT activity
  • 10. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity B. Elevated PTEN expression is related to reduced phospho- AKT activity C. Effect of derepressed PTEN is growth inhibition
  • 11. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity B. Elevated PTEN expression is related to reduced phospho- AKT activity C. Effect of derepressed PTEN is growth inhibition D. PTENP1 3’ UTR is a more potent growth suppressor than PTEN ▫ Could function as a decoy for miRNAs that bind to other targets with tumour suppressive activities
  • 12. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity E. Disruption of DICER blunts derepression of PTEN by PTENP1 3’ UTR ▫ Suggests PTENP1 3’ UTR requires mature miRNA for function
  • 13. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity E. Disruption of DICER blunts derepression of PTEN by PTENP1 3’ UTR ▫ Suggests PTENP1 3’ UTR siRNA function in RNA interferencemature miRNA for requires to degrade mRNA, function introducing siRNA can have the F. Silencing both PTEN and effect of “knocking-down” or PTENP1 showed strongest “silencing” genes increase in cell proliferation ▫ Suggests additive roles for PTEN and PTENP1 in growth suppression
  • 14. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity E. Disruption of DICER blunts derepression of PTEN by PTENP1 3’ UTR ▫ Suggests PTENP1 3’ UTR requires mature miRNA for function F. Silencing both PTEN and PTENP1 showed strongest increase in cell proliferation ▫ Suggests additive roles for PTEN and PTENP1 in growth suppression
  • 15. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity G. siRNA knockdown decreased PTEN and PTENP1 mRNA
  • 16. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion 2. The 3’ UTR of PTENP1 has tumor suppressive activity G. siRNA knockdown decreased PTEN and PTENP1 mRNA H. siRNA knockdown also decreased PTEN protein abundance
  • 17. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 3 Fig. 4 Conclusion 3. PTENP1 levels influence downregulation of PTEN in cancer cells A., B. PTEN and PTENP1 expression are co-regulated  Method: Quantitative RT PCR, measured by green fluorescence (Taqman)  Direct correlation between PTEN and PTENP1 expression in both normal tissue and tumour samples (r = 0.8087 and 0.7538; P<0.0001) C. In colon cancer samples, independent copy number losses occur specifically in PTENP1 gene  Copy number losses in PTENP1 occur due to selective pressure in cancer
  • 18. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 3 Fig. 4 Conclusion 3. PTENP1 levels influence downregulation of PTEN in cancer cells D. PTEN expression is downregulated in cancer cells E. PTENP1 transcript levels regulate PTEN expression ▫ Direct correlation between log ratio of PTENP1 copy number vs. log10 PTEN expression intensity 1. r = 0.6105, P = 0.0092 2. r = 0.6056, P = 0.0129
  • 19. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Fig. 4 Conclusion 4. Model should work for other genes A. PTEN 3’ UTR derepresses PTENP1 mRNA and shows growth suppression B. KRAS and its pseudogene show similar regulatory mechanisms. ▫ It is known that K1P 3’ UTR overexpression leads to increased levels of KRAS, and consequently cell proliferation and accelerated cell growth
  • 20. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Fig. 4 Conclusion 4. Model should work for other genes C. RNAs X and Y in this figure can be thought of as a pseudogene and its cognate protein coding gene. ▫ In Case 1, the downregulation of RNA X leads to increased binding sites for the miRNA on RNA Y, causing RNA Y to be repressed. ▫ In Case 2, both RNA X and RNA Y are in equilibrium ▫ In Case 3, RNA X is overexpressed and act as an miRNA sponge, this derepresses RNA Y
  • 21. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion Conclusion • Scientists have discovered a new dimension by which cellular and tumor biology can be regulated • Pseudogenes were once considered non- functional, but are now known to affect mRNA transcript abundance through a miRNA binding mechanism
  • 22. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion References • http://www.jyi.org/features/ft.php?id=392 • http://www.answersingenesis.org/tj/v17/i2/pse udogene.asp • Nature, Vol 465, 24 June 2010, A coding- independent function of gene and pseudogene mRNAs regulates tumour biology
  • 23. Intro Main Pts Results: Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion

Notes de l'éditeur

  1. Colored lines?
  2. PTENP1 3’ UTR inserted into DU145 cells using retroviral vectorsPTENP1 3’ UTR expression derepressed PTEN transcription and translation